FIBCLOT

This brand name is authorized in Austria, Spain, Finland, United Kingdom

Active ingredients

The drug FIBCLOT contains one active pharmaceutical ingredient (API):

1 Human fibrinogen UNII N94833051K - FIBRINOGEN HUMAN

Human fibrinogen (coagulation factor I), in the presence of thrombin, activated coagulation factor XIII (F XIIIa) and calcium ions is converted into a stable and elastic three-dimensional fibrin haemostatic clot. The administration of human fibrinogen concentrate provides an increase in plasma fibrinogen level and can temporarily correct the coagulation defect of patients with fibrinogen deficiency. Read about Human fibrinogen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BB01	Human fibrinogen	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BB Fibrinogen
Discover more medicines within B02BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 81021
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 398526
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 341625